Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anktiva comment

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Apr 26, 2024 9:21pm

141 Views

Post# 36010605

RE:RE:RE:Anktiva comment

enriquesuave wrote:
IBRX just gained $1.3 Billion US today in MC. Now at $5 Billion MC. At the same MC we would be at $15 USD or $21 CAD . We should be at least 20% of that value after BTD. IMHO

menoalittle wrote: >> One other challenge with Anktiva is the tethering to BCG.

I can't confirm this, but I've heard that (at least some) insurance companies are not wanting to pay for the 14 or 18 (I forget what the standard is) treatments of BCG... at (did I hear this right?) over a hundred thousand each?

This reaction must be about their news on small cell lung cancer -- there was not much reaction to the bladder cancer results.